TAZTIA - 62037-699-30 - (Diltiazem Hydrochloride)

Alphabetical Index


Drug Information of TAZTIA

Product NDC: 62037-699
Proprietary Name: TAZTIA
Non Proprietary Name: Diltiazem Hydrochloride
Active Ingredient(s): 300    mg/1 & nbsp;   Diltiazem Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of TAZTIA

Product NDC: 62037-699
Labeler Name: Watson Pharma, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075401
Marketing Category: ANDA
Start Marketing Date: 20030410

Package Information of TAZTIA

Package NDC: 62037-699-30
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-699-30)

NDC Information of TAZTIA

NDC Code 62037-699-30
Proprietary Name TAZTIA
Package Description 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-699-30)
Product NDC 62037-699
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Diltiazem Hydrochloride
Dosage Form Name CAPSULE, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20030410
Marketing Category Name ANDA
Labeler Name Watson Pharma, Inc.
Substance Name DILTIAZEM HYDROCHLORIDE
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC]

Complete Information of TAZTIA


General Information